WAY-271413 is primarily used in neuroscience research as a selective agonist for the 5-HT6 receptor subtype. Its main application lies in studying cognitive functions, memory processes, and neurodegenerative conditions such as Alzheimer's disease. Due to its ability to modulate serotonin signaling in the central nervous system, it is employed in preclinical studies to evaluate potential cognitive enhancers and novel treatments for psychiatric disorders including schizophrenia and depression. It is also utilized in receptor binding assays and functional assays to characterize the pharmacological profile of 5-HT6 ligands. Its high selectivity makes it a valuable tool compound in distinguishing 5-HT6-mediated effects from those involving other serotonin receptor subtypes.